Earnings Call · Q4 FY2021·2022-03-03

Q4 21EPS -89.31%·Rev n/aQ3 21EPS +2.10%·Rev n/aQ2 21EPS +30.77%·Rev n/aQ1 21EPS -7.69%·Rev n/a⚠ consensus missing

Evofem Biosciences, Inc. EVFM

Amy Raskopf — Vice President of Investor Relations

Saundra Pelletier — Chief Executive Officer

Jay File — Chief Financial Officer

+22.9%1d on move date+24.0% vs SPY3d+6.0%5d+3.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more EVFM calls or request research access.

More EVFM calls Browse calls Request research access